MHRA

How regulation can spark life-saving innovation.

Developers work with the NHS, the medicines regulator and the UK health technology assessment bodies from the early stages of clinical development, as part of the Innovative Licensing and Access Pathway.

The MHRA produces over 95 per cent of the World Health Organization’s (WHO) biological standards.

List of Field Safety Notices from 6 October to 10 October 2025.

The MHRA’s Interim Executive Director of Science and Research writes in The British Medical Journal on the approval of the UK’s first new UTI antibiotic in nearly 30 years, and the wider challenge of tackling antibiotic resistance.

Aligned pathway will streamline decisions on licensing and value for medicines, helping patients to benefit from them sooner.

Enhanced collaboration with the US on med tech regulation, with accelerated innovation, strengthened patient safety, and reduced transatlantic barriers to market access.

List of Field Safety Notices from 29 September to 3 October 2025.

Patients receive earlier access to life-saving treatments as UK trial approval times cut in half from 91 to just 41 days.

The BodyComm software currently uses Windows 10. Microsoft is transitioning to Windows 11 from 14 October 2025 which requires an updated cable to connect the pumps to the BodyComm software. These cables may not be available until after the Windows transition date.

The MHRA is inviting the next generation of doctors to explore how genetics could improve prescribing and patient safety in the UK.

Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines.